Skip to main content

Portfolio

HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.

Overview as at 31 March 2019

Currency allocation of assets

Emphasis on US dollar investments

56 340 US dollar (USD) 74 Euro (EUR) 10 Swiss franc (CHF) 7 Other currencies (CAD, DKK, INR, SEK) 6 British pound (GBP) 3 #008D6C #A1564C #89733F #87AFB1 #54465D #D4A42A #B1AB8E #255B8E #5C5A4F #323D4A
Allocation of assets

Mainly invested in private companies or in companies originating
from the private companies portfolio.

62 340 Public companies 45 Private companies 26 Funds 9 Cash and cash equivalents 17 Other assets 3 #008D6C #A1564C #89733F #87AFB1 #54465D #D4A42A #B1AB8E #255B8E #5C5A4F #323D4A
Development phase of portfolio companies

Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.

69 90 Products on the market 22 Phase III 34 Phase II 26 Phase I 2 Preclinical 1 Profitable 15 #008D6C #A1564C #89733F #87AFB1 #54465D #D4A42A #B1AB8E #255B8E #5C5A4F #323D4A
Therapeutic area of the lead product of portfolio companies

Broadly diversified areas of activity.

79 350 Others 30 Orphan diseases 23 Oncology 14 Central nervous system 9 Autoimmune diseases 7 Medical technology / diagnostics 5 Digital Health 5 Metabolic diseases 4 Infectious diseases 3 #008D6C #A1564C #89733F #87AFB1 #54465D #D4A42A #B1AB8E #255B8E #5C5A4F #323D4A